Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_assertion type Assertion NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_head.
- NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_assertion description "[Seven patients with HCC who underwent transcatheter arterial embolization (TAE) exhibited a gradual increase in serum HGF levels up to day 4 after treatment; these higher levels were maintained until day 7, although AST reached a peak on day 2 and then decreased gradually.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_provenance.
- NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_assertion evidence source_evidence_literature NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_provenance.
- NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_assertion SIO_000772 7806142 NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_provenance.
- NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_assertion wasDerivedFrom befree-2016 NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_provenance.
- NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_assertion wasGeneratedBy ECO_0000203 NP1322439.RAqa-3QOjuzdkDgldkW5j3BJ5H9BDOiTlMn-IL5VfVQyc130_provenance.